Dispensing patterns for antidiabetic agents in New Zealand: are the guidelines being followed?

Authors:
  • PMPeter Murray
    Peter Murray
  • HNHew Norris
    Hew Norris
  • BBBryan Betty
    Bryan Betty
  • VYVanessa Young
    Vanessa Young
  • BLBronwyn Locke
    Bronwyn Locke

  • 10 November 2017
    • journal article
Abstract
Type 2 diabetes mellitus (T2DM) is a significant public health issue in New Zealand. Effective management and glycaemic control is critical for reducing diabetes-related complications. Treatment guidelines are well established in New Zealand. Using dispensing data as a proxy for prescribing data, this paper aims to describe the pattern of first- and second-line antidiabetic agent (AA) dispensing for T2DM in New Zealand and assess adherence with treatment guidelines.